Back

Optimization of high-power short-duration pulmonary vein isolation using QDOT catheter - the A-Q-RATE POWER trial

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: treatment 6 - ablation Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Piotr Gardziejczyk

Medical University of Warsaw, Warsaw (Poland)

6 More presentations in this session

Presentation thumbnail
Conduction velocity-based functional substrate mapping during atrial fibrillation (AF) enhances identification of AF drivers compared to mapping during sinus rhythm
Doctor A. Sharp (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation cryoablation guided by pressure waveform: a prospective multicentre registry
Doctor A. Fontenla Cerezuela (Pozuelo de Alarcon, Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Pattern of reconnection after isolation of the pulmonary veins with a pulsed-field ablation.
Doctor F. Finet (Clermont-Ferrand, FR)
Abstract Slides Video
Presentation thumbnail
Impact of the timing of early recurrences during the blanking period in patients after cryoballoon ablation: insights from the COMPARE CRYO study using continuous rhythm monitoring
Doctor S. Iqbal (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Peak frequency can be effectively used to characterize atrial remodelling in atrial fibrillation
Doctor S. Al-Aidarous (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: treatment 6 - ablation

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Enhancing efficiency in pulmonary vein isolation: hybrid high-power strategy with consistent long-term recurrence rates
thumbnail
Congress Presentation
Procedural characteristics of very high-power short-duration compared to ablation index-guided ablation for pulmonary vein isolation in atrial fibrillation patients
thumbnail
Congress Presentation
Efficiency, efficacy and safety of very high-power short-duration radiofrequency atrial fibrillation ablation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources